• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏大小在评估人体药物代谢能力中的作用。

Liver size in evaluating drug metabolizing capacity in man.

作者信息

Pirttiaho H

出版信息

Int J Clin Pharmacol Biopharm. 1979 Jun;17(6):271-6.

PMID:468452
Abstract

Liver size, cytochrome P-450 (P-450) concentration in liver biopsy specimens and antipyrine kinetics were studied in 112 consecutive patients undergoing diagnostic liver biopsy. Compared to subjects with normal parenchyma, those with slight or severe parenchymal alterations had enlarged livers with low P-450 concentration and slow antipyrine elimination. In the normal group, the mean P-450 concentration (+/- 1 SD) was 11.10 +/- 2.14 nmol/g liver tissue and the total amount (estimated liver weight g X P-450 concentration nmol/g) 16.06 +/- 3.29 mumol. Previous therapy with enzyme inducing drugs was associated with enlarged liver in subjects with normal histological findings and with fast antipyrine elimination and high P-450 in all groups. Antipyrine elimination rate correlated with liver weight only in subjects with normal parenchyma. The total amount of P-450 was generally more closely related to its concentration than to the estimated liver weight, although in many individual cases a large liver was able to compensate a low P-450 concentration so that the total P-450 was at the normal level. Despite normal or high total P-450, in vivo drug metabolism was impaired in subjects with altered parenchyma, suggesting that other factors were limiting antipyrine elimination in liver disease.

摘要

对112例接受诊断性肝活检的连续患者进行了肝脏大小、肝活检标本中细胞色素P - 450(P - 450)浓度及安替比林动力学研究。与实质正常的受试者相比,实质有轻度或重度改变的受试者肝脏增大,P - 450浓度降低,安替比林消除缓慢。正常组中,肝组织P - 450平均浓度(±1标准差)为11.10±2.14 nmol/g,总量(估计肝脏重量g×P - 450浓度nmol/g)为16.06±3.29 μmol。既往使用酶诱导药物治疗与组织学表现正常的受试者肝脏增大、所有组中安替比林快速消除及P - 450升高有关。仅在实质正常的受试者中,安替比林消除率与肝脏重量相关。P - 450总量一般与其浓度的关系比与估计肝脏重量的关系更密切,尽管在许多个体病例中,大肝脏能够补偿低P - 450浓度,使P - 450总量处于正常水平。尽管P - 450总量正常或升高,但实质改变的受试者体内药物代谢受损,提示其他因素限制了肝病患者安替比林的消除。

相似文献

1
Liver size in evaluating drug metabolizing capacity in man.肝脏大小在评估人体药物代谢能力中的作用。
Int J Clin Pharmacol Biopharm. 1979 Jun;17(6):271-6.
2
Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.无肝脏疾病人群中安替比林代谢清除率与肝微粒体药物氧化酶活性之间的关系。
Gastroenterology. 1981 Jan;80(1):112-8.
3
[Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].[肝脏疾病中药物代谢酶系统的定量分析:安替比林唾液清除率与氨基比林呼吸试验的比较]
Schweiz Med Wochenschr. 1985 May 11;115(19):651-8.
4
[Monooxigenase activity in liver diseases (study based on data of antipyrine metabolism)].[肝脏疾病中的单加氧酶活性(基于安替比林代谢数据的研究)]
Ter Arkh. 1987;59(2):84-9.
5
[The antipyrine test in occupational medicine research--evaluation of individual reproducibility and frequency distribution of half-life].[职业医学研究中的安替比林试验——个体重现性及半衰期频率分布评估]
Z Gesamte Hyg. 1989 Feb;35(2):82-4.
6
Exercise training does not alter cytochrome P-450 content and microsomal metabolism.运动训练不会改变细胞色素P-450的含量和微粒体代谢。
Med Sci Sports Exerc. 1994 Aug;26(8):978-82.
7
Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.体外人肝脏中细胞色素P-450与苯并[a]芘和7-乙氧基香豆素氧化代谢及体内安替比林消除之间的相关性。
Drug Metab Dispos. 1980 Jul-Aug;8(4):218-22.
8
Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.β-肾上腺素受体阻断药与细胞色素P-450:普萘洛尔治疗对肝病患者咖啡因、安替比林、D-葡萄糖醛酸和吲哚菁绿消除的影响
Int J Clin Pharmacol Res. 1986;6(3):235-9.
9
Liver size and indices of drug metabolism in alcoholics.
Eur J Clin Pharmacol. 1978 Mar 17;13(1):61-7. doi: 10.1007/BF00606684.
10
[Effect of various liver diseases on the activity of 2 subtypes of cytochrome P-450].
Dtsch Z Verdau Stoffwechselkr. 1987;47(1):1-13.

引用本文的文献

1
Body surface area as a determinant of pharmacokinetics and drug dosing.体表面积作为药代动力学和药物剂量确定的一个因素。
Invest New Drugs. 2001 May;19(2):171-7. doi: 10.1023/a:1010639201787.
2
Relationships among liver and kidney volumes, lean body mass and drug clearance.肝脏和肾脏体积、瘦体重与药物清除率之间的关系。
Br J Clin Pharmacol. 1998 Nov;46(5):447-52. doi: 10.1046/j.1365-2125.1998.00812.x.
3
Lean body mass as a predictor of drug dosage. Implications for drug therapy.瘦体重作为药物剂量的预测指标。对药物治疗的启示。
Clin Pharmacokinet. 1994 Apr;26(4):292-307. doi: 10.2165/00003088-199426040-00005.
4
Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.肝血流量和酶活性在普萘洛尔和索他洛尔动力学中的作用。
Br J Clin Pharmacol. 1980 Apr;9(4):399-405. doi: 10.1111/j.1365-2125.1980.tb01068.x.
5
Cholestasis and hepatic drug metabolism. Comparison of metabolic clearance rate of antipyrine in patients with intrahepatic or extrahepatic cholestasis.胆汁淤积与肝脏药物代谢。肝内或肝外胆汁淤积患者中安替比林代谢清除率的比较。
Dig Dis Sci. 1981 Aug;26(8):718-22. doi: 10.1007/BF01316861.
6
Relationships between plasma theophylline clearance, liver volume and body weight in children and adults.儿童和成人血浆茶碱清除率、肝脏体积与体重之间的关系。
Eur J Clin Pharmacol. 1983;24(4):529-32. doi: 10.1007/BF00609898.